Why did Meta hire OpenAI researchers recently?
How did Trump gain veto power over U.S. Steel?
What caused U.S. economy to shrink in early 2025?
Why are Bitcoin ETFs seeing major inflows now?
How is AI reshaping marketing strategies?
What impact did U.S. strikes have on Iran's nuclear sites?
Why is Bumble cutting 30% of its workforce?
Kymera weakness a buying opportunity, says Stifel
finance.yahoo.com/news/kymera-weakness-buying-opportunity-says-144542066.html
In This Article:
Stifel analyst Alex Thompson is reiterating a Buy rating on Kymera Therapeutics (KYMR) following “a slate of updates,” including the decision by partner Sanofi (SNY) to discontinue development of lead IRAK4 degrader KT-474 in favor of next-gen KT-485 and a new…
This story appeared on finance.yahoo.com, 2025-06-26 14:45:42.